» Articles » PMID: 32725081

Clostridium Difficile Toxins or Infection Induce Upregulation of Adenosine Receptors and IL-6 with Early Pro-inflammatory and Late Anti-inflammatory Pattern

Overview
Date 2020 Jul 30
PMID 32725081
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium difficile causes intestinal inflammation, which increases adenosine. We compared the expression of adenosine receptors (AR) subtypes A1, A2A, A2B, and A3 in HCT-8, IEC-6 cells, and isolated intestinal epithelial cells, challenged or not with Clostridium difficile toxin A and B (TcdA and TcdB) or infection (CDI). In HCT-8, TcdB induced an early A2BR expression at 6 h and a late A2AR expression at 6 and 24 h. In addition, both TcdA and TcdB increased IL-6 expression at all time-points (peak at 6 h) and PSB603, an A2BR antagonist, decreased IL-6 expression and production. In isolated cecum epithelial cells, TcdA induced an early expression of A2BR at 2s and 6 h, followed by a late expression of A2AR at 6 and 24 h and of A1R at 24 h. In CDI, A2AR and A2BR expressions were increased at day 3, but not at day 7. ARs play a role in regulating inflammation during CDI by inducing an early pro-inflammatory and a late anti-inflammatory response. The timing of interventions with AR antagonist or agonists may be of relevance in treatment of CDI.

Citing Articles

Cytotoxic synergism of toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases.

Bassotti G, Fruganti A, Stracci F, Marconi P, Fettucciari K World J Gastroenterol. 2023; 29(4):582-596.

PMID: 36742168 PMC: 9896618. DOI: 10.3748/wjg.v29.i4.582.


Adenosine receptors differentially mediate enteric glial cell death induced by Toxins A and B.

Costa D, Shin J, Goldbeck S, Bolick D, Mesquita F, Loureiro A Front Immunol. 2023; 13:956326.

PMID: 36726986 PMC: 9885079. DOI: 10.3389/fimmu.2022.956326.


Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice.

Kotanska M, Dziubina A, Szafarz M, Mika K, Bednarski M, Nicosia N Int J Mol Sci. 2022; 23(21).

PMID: 36362227 PMC: 9656786. DOI: 10.3390/ijms232113439.


Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro.

Azimirad M, Noori M, Azimirad F, Gholami F, Naseri K, Yadegar A Ann Clin Microbiol Antimicrob. 2022; 21(1):41.

PMID: 36155114 PMC: 9511736. DOI: 10.1186/s12941-022-00533-3.


How Does COVID-19 Pandemic Impact on Incidence of Infection and Exacerbation of Its Gastrointestinal Symptoms?.

Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Aghdaei H Front Med (Lausanne). 2021; 8:775063.

PMID: 34966759 PMC: 8710593. DOI: 10.3389/fmed.2021.775063.


References
1.
Christofi F, Zhang H, Yu J, Guzman J, Xue J, Kim M . Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol. 2001; 439(1):46-64. DOI: 10.1002/cne.1334. View

2.
Warren C, Li Y, Calabrese G, Freire R, Zaja-Milatovic S, van Opstal E . Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection. Infect Immun. 2012; 80(12):4463-73. PMC: 3497433. DOI: 10.1128/IAI.00782-12. View

3.
Sullivan G, Rieger J, Scheld W, Macdonald T, Linden J . Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol. 2001; 132(5):1017-26. PMC: 1572638. DOI: 10.1038/sj.bjp.0703893. View

4.
Wei W, Du C, Lv J, Zhao G, Li Z, Wu Z . Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. J Immunol. 2012; 190(1):138-46. PMC: 3539684. DOI: 10.4049/jimmunol.1103721. View

5.
Zaynagetdinov R, Ryzhov S, Goldstein A, Yin H, Novitskiy S, Goleniewska K . Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. Am J Respir Cell Mol Biol. 2009; 42(5):564-71. PMC: 2874442. DOI: 10.1165/rcmb.2008-0391OC. View